The combination of amlodipine 5 mg and valsartan 160 mg lowers blood pressure effectively and safely in hypertensive patients with metabolic risk factors not controlled by monotherapy with calcium channel blockers

被引：0
|
作者：
Brachmann, J. [1 ]
Handrock, R. [2 ]
Klebs, S. [2 ]
机构：
[1] Coburg Hosp, Dept Cardiol, Coburg, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
来源：
CIRCULATION | 2008年 / 118卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E287 / E287
页数：1
相关论文
共 50 条
  • [21] Valsartan 160/HCTZ 25 effectively reduces blood pressure in hypertensive patients not controlled by valsartan 160/HCTZ 12.5
    Trenkwalder, P
    Ulmer, HJ
    Wolf, H
    Handrock, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S391 - S391
  • [22] Valsartan 160/HCTZ 25 effectively reduces blood pressure in hypertensive patients not controlled by valsartan 160/HCTZ 12.5
    Trenkwalder, P
    Ulmer, HJ
    Wolf, H
    Handrock, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S194 - S194
  • [23] Efficacy and tolerability of HCTZ 25 mg in combination with valsartan 160 mg in hypertensive patients not adequately controlled with a combination of high doses of ARBs and HCTZ 12,5 mg
    Girerd, X
    Denolle, T
    Brunel, P
    Yau, C
    Fiquet, B
    Moulin, B
    Herpin, D
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 107A - 108A
  • [24] EFFICACY OF AN AMLODIPINE/VALSARTAN COMBINATION ON BLOOD PRESSURE CONTROL, WITH ONE EVENING OR MORNING INTAKE A DAY, IN ESSENTIAL HYPERTENSIVE PATIENTS UNCONTROLLED WITH AMLODIPINE 5 MG: EXPERT STUDY
    Asmar, R.
    Gosse, R.
    Achouba, A.
    JOURNAL OF HYPERTENSION, 2009, 27 : S8 - S8
  • [25] Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy
    Tuomilehto, Jaakko
    Tykarski, Andrzej
    Baumgart, Peter
    Reimund, Bernard
    Le Breton, Stephanie
    Ferber, Philippe
    BLOOD PRESSURE, 2008, 17 : 15 - 23
  • [26] Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination
    Schweizer, J.
    Hilsmann, U.
    Neumann, G.
    Handrock, R.
    Klebs, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2877 - 2885
  • [27] An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy
    Foch, Caroline
    Feifel, Jan
    Gottwald-Hostalek, Ulrike
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (04) : 587 - 593
  • [28] Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension:: The blood pressure reduction and tolerability of valsartan in comparison with lisinopril (PREVAIL) study
    Malacco, E
    Santonastaso, M
    Varì, NA
    Gargiulo, A
    Spagnuolo, V
    Bertocchi, F
    Palatini, P
    Fogari, R
    Perna, GP
    Paci, MV
    di Ancona, T
    Arnaldi, G
    Boscaro, M
    Pedace, C
    Moretti, L
    Piceno, A
    Pinna, G
    Rosato, G
    Maina, M
    Baldini, A
    Chimini, C
    Proto, C
    Destro, M
    Maxia, P
    Meloni, L
    Vaccarella, A
    Gargiulo, A
    Ronchi, E
    Cannone, M
    Olivieri, L
    Rossi, A
    Turchetti, CG
    Sprovieri, M
    Ansuini, R
    Gruppillo, P
    Caiazza, A
    Di Taranto, A
    Aquilina, M
    Costa, PL
    Santilli, E
    Zecca, A
    Percio, E
    Dassi, S
    Grechi, P
    Sommariva, D
    Santucci, A
    Tascione, E
    Magliari, E
    Locatelli, F
    Rigatelli, F
    CLINICAL THERAPEUTICS, 2004, 26 (06) : 855 - 865
  • [29] Efficacy and safety of the combination of amlodipine 10/valsartan 160 in patients with hypertension and metabolic risk factors not controlled by the combination of ramipril 5/felodipine 5 - A subanalysis of the EXPRESS-C trial
    Trenkwalder, P.
    Schaetzl, R.
    Borbas, E.
    Handrock, R.
    Klebs, S.
    JOURNAL OF HYPERTENSION, 2007, 25 : S229 - S229
  • [30] Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension
    Yagi, Shusuke
    Takashima, Akira
    Mitsugi, Minoru
    Wada, Toshihiro
    Hotchi, Junko
    Aihara, Ken-ichi
    Hara, Tomoya
    Ishida, Masayoshi
    Fukuda, Daiju
    Ise, Takayuki
    Yamaguchi, Koji
    Tobiume, Takeshi
    Iwase, Takashi
    Yamada, Hirotsugu
    Soeki, Takeshi
    Wakatsuki, Tetsuzo
    Shimabukuro, Michio
    Akaike, Masashi
    Sata, Masataka
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 83 - 88
12345